Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

Reimagining Healthcare Through Integrated Digital Health Empowerment

Yianni Serpanos, Founder & CEO of HealthTechX, discusses a variety of topics, including how COVID-19 has affected the uptake of telehealth among allied health professionals in Australia and worldwide. Yianni also...

Impetus Digital

- PMLiVE

Porterhouse Medical Hub, Nottingham: The latest development for the Porterhouse Medical Group

As part of our continued expansion and the expansion of imc group, Porterhouse Medical Group, global insight-led scientific and medical communications agency, is delighted to announce the opening of our latest...

Porterhouse Medical Group

- PMLiVE

Digital Therapeutics Landscape in Europe

OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

OPEN Health

- PMLiVE

Standard steroid improves recovery of critically-ill COVID-19 patients

The study evaluated hydrocortisone in 403 patients with suspected or confirmed COVID-19

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Inizio

- PMLiVE

OPEN Health’s virtual reflections on the World Orphan Drug Congress US

Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. It was great to be joined by many colleagues from all our...

OPEN Health

Roche Basel Switzerland

Roche plans to launch rapid COVID-19 antigen test later this month

Swiss pharma also intends to file for emergency approval in the US

AstraZeneca AZ

AZ’s Farxiga cuts risk of death in chronic kidney disease

Detailed results revealed at the European Society of Cardiology virtual congress

Guide

UX research

Inizio

Article: Why pharma must trust the science of behaviour

In a recent interview with PME Magazine, Dan Coffin, Director explains why the application of behavioural science will be key to better health far beyond COVID-19.Read the full article here:...

Inizio

Case study

Using qualitative conjoint to assess willingness-to-pay

Inizio

- PMLiVE

Nestlé is set to acquire Aimmune in deal worth $2.6bn

Aimmune’s Palforzia therapy is the only FDA-approved peanut allergy drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links